Inventaire - your friends and communities are your best library - Inventaire

Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms

author

Gregory Petsko

published in: Journal of Parkinson's disease

date of publication: 2018

language: English

main subject: Parkinson's disease, skin neoplasm

Cites articles 127

Date

Title

Authors

2017-07-01

Parkinson Disease and Melanoma: Confirming and Reexamining an Association

Barbara P Yawn
2017-06-05

Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death

Michael R Schön, Tiago Fleming Outeiro
2016-12-26

The melanoma-linked "redhead" MC1R influences dopaminergic neuron survival

Michael A Schwarzschild, David E. Fisher, Charles R Vanderburg
2016-10-19

Cutaneous malignant melanoma and Parkinson disease: Common pathways?

Rivka Inzelberg
2016-07-28

Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease

Alan Pittman, Jose Bras, Peter Heutink, Matthew H Law, Florence Demenais, Mark M Iles, Timothy Bishop, Julia A Newton Bishop
2016-08-05

Prodromal symptoms of Parkinson's disease: Implications for epidemiological studies of disease etiology
2016-05-13

Parkin Somatic Mutations Link Melanoma and Parkinson's Disease

Ora Schueler-Furman, Tamar Ziv, Yardena Samuels
2015-08-18

Nicotine and Nicotinic Receptor Drugs: Potential for Parkinson's Disease and Drug-Induced Movement Disorders
2015-03-27

Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma

Uwe Walter
2015-03-13

The MC1R melanoma risk variant p.R160W is associated with Parkinson disease

Rubén Fernández-Santiago, Susana Puig, Gemma Tell-Martí, Miriam Potrony, Celia Badenas, Montserrat Milà, Josep Malvehy, Mario Ezquerra, Joan Anton Puig-Butille
2014-10-05

The melanocortin 1 receptor (Mc1r) variants do not account for the co-occurrence of Parkinson's disease and malignant melanoma.

Rivka Inzelberg, Yael Laitman
2014-06-28

The prevalence of Parkinson's disease: a systematic review and meta-analysis

Nathalie Jetté
2013-12-03

Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial

Karl Kieburtz
2013-03-27

Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines
2013-02-01

Melanocortins as innovative drugs for ischemic diseases and neurodegenerative disorders: established data and perspectives

Giorgio Noera
2012-10-31

Sonographic abnormality of the substantia nigra in melanoma patients
2010-12-02

Mutations in GNA11 in uveal melanoma

Klaus Busam, Catherine D Van Raamsdonk, Anna C Obenauf, Werner Wackernagel, Igor Dolgalev, Thomas Wiesner, Klaus G Griewank, Michael R. Speicher, Boris C. Bastian
2010-11-01

Common pathogenic pathways in melanoma and Parkinson disease

Coro Paisán-Ruíz
2010-08-09

Chaperone-mediated autophagy markers in Parkinson disease brains

Lydia Alvarez-Erviti, Maria Cruz Rodriguez Oroz, Anthony H V Schapira, J M Cooper
2010-09-01

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease.

Anthony Lang, Christopher G. Goetz, Stanley Fahn, Karl Kieburtz, Caroline M Tanner, Ira Shoulson, David Oakes
2010-06-01

HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase

Christof Fellmann, Michael Otmar Hengartner
2010-05-05

Parkinson's disease-related protein, alpha-synuclein, in malignant melanoma

Yasuhiro Matsuo
2010-05-01

A case-control study of Parkinson's disease and tobacco use: gene-tobacco interactions.

Neva Haites
2010-04-26

Genetic determinants at the interface of cancer and neurodegenerative disease
2010-02-02

Endogenous 3,4-dihydroxyphenylalanine and dopaquinone modifications on protein tyrosine: links to mitochondrially derived oxidative stress via hydroxyl radical

Joel G. Pounds, Richard D. Smith, Athena A Schepmoes, Jöns Jacob Berzelius, Matthew E Monroe, François-David Camps, Brianne O Petritis, Diana J Bigelow, Wei-Jun Qian, Tyler Heibeck
2010-01-07

Parkinson's disease and cancer risk: a systematic review and meta-analysis

Eva Schernhammer
2010-03

Cancer risk in association with Parkinson disease: A population-based study

Saga Johansson
2010-02-01

alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure
2010-03-01

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

Tania J Phillips, Mark F. Lew
2010-10-29

Cancer: Targeting mutant BRAF in metastatic melanoma

Alexandra Flemming
2009-11-29

Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies

Chris Sander, Marc Ladanyi, Igor Vivanco, Nikolaus Schultz, William Pao, Timothy F. Cloughesy, Linda Liau, David B Solit, Selvaraju Veeriah, Shasha Meng, Philip Paty, Paul Mischel, Adriana Heguy, Ingo K Mellinghoff, Aphrothiti J Hanrahan, Manickam Janakiraman
2009-10-01

Family history of melanoma and Parkinson disease risk.

Alberto Ascherio

Article - wd:Q58779911

Welcome to Inventaire

the library of your friends and communities

you are offline